Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine.

about

OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study.Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life.

P2860

Q37650532-FB67693B-9C8C-445A-8BCD-3E983561DF78 Q47244918-86910BAC-BBCA-400F-8A9C-F3880ACF8B89

P2860

Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine.

Item

http://www.wikidata.org/entity/Q47410678

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Effects of onabotulinumtoxinA ...... atients with chronic migraine.

@en

Effects of onabotulinumtoxinA ...... atients with chronic migraine.

@nl

type

Item

label

Effects of onabotulinumtoxinA ...... atients with chronic migraine.

@en

Effects of onabotulinumtoxinA ...... atients with chronic migraine.

@nl

prefLabel

Effects of onabotulinumtoxinA ...... atients with chronic migraine.

@en

Effects of onabotulinumtoxinA ...... atients with chronic migraine.

@nl

P1476

Effects of onabotulinumtoxinA ...... atients with chronic migraine.

@en

P2093

Atilla Tekin

http://www.w3.org/2001/XMLSchema#string

Bekir Enes Demiryurek

http://www.w3.org/2001/XMLSchema#string

Belma Dogan Gungen

http://www.w3.org/2001/XMLSchema#string

Devrimsel Harika Ertem

http://www.w3.org/2001/XMLSchema#string

Mustafa Ceylan

http://www.w3.org/2001/XMLSchema#string

Yesim Guzey Aras

http://www.w3.org/2001/XMLSchema#string

P2860

An Inventory for Measuring Depression

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

Development of onabotulinumtoxinA for chronic migraine

The International Classification of Headache Disorders, 3rd edition (beta version)

Migraine and its psychiatric comorbidities.

Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.

OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.

Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety.

Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A.

Migraine incidence in 5 years: a population-based prospective longitudinal study in Turkey.

P2888

s10072-016-2665-z

P304

1779-1784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10072-016-2665-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27418178

http://www.w3.org/2001/XMLSchema#string

Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine.

about

P2860

P2860

Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698